Healthcare -
Biotechnology - NASDAQ - GB
$ 10.505
-2.19 %
$ 7.5 B
Market Cap
-10.5
P/E
ROIV - OPERATING INCOME
Operating Income ROIV - Roivant Sciences Ltd.
4.24 B
LAST VALUE
126.68%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR